AVANIR PHARMACEUTICALS DOCS® Financing Program 5,684,000 Shares of Class A Common Stock, no par value SALES AGREEMENT December 15, 2006Sales Agreement • June 4th, 2007 • Avanir Pharmaceuticals • Pharmaceutical preparations • New York
THIS SALES AGREEMENT (the “Agreement”) dated as of December 15, 2006 between Brinson Patrick Securities Corporation, having its principal office at 330 Madison Avenue, 9th Floor, New York, New York 10017 (the “Sales Manager”) and Avanir Pharmaceuticals, a corporation organized and existing under the laws of the State of California (the “Company”).
AMENDMENT NO. 1 TO SALES AGREEMENTSales Agreement • June 4th, 2007 • Avanir Pharmaceuticals • Pharmaceutical preparations • New York
This AMENDMENT NO. 1 TO SALES AGREEMENT (the “Amendment”), dated June 4, 2007, is made and entered into by and between Brinson Patrick Securities Corporation, having its principal office at 330 Madison Avenue, 9th Floor, New York, New York 10017 (the “Sales Manager”) and Avanir Pharmaceuticals, a corporation organized and existing under the laws of the State of California (the “Company”).
